乌鸦传媒

Remission of coexisting conditions was also maintained, long-term data show

Patients taking the GLP-1 drug also had greater improvement in physical function

New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents

However, 24 weeks of the GLP-1 had no impact on eGFR

GLP-1 receptor agonists may have better protective benefits versus metformin, insulin

Findings leave researcher "concerned"

News and commentary from the endocrinology world

Conundrum of holding meds continues following conflicting reports of aspiration events

Health news and commentary gathered by 乌鸦传媒 staff

News and commentary from the endocrinology world

But Japanese study suggests losses need to be substantial

GLP-1 treatment was tied to lower risks of suicidal ideation, attempts vs lifestyle interventions

Including lipids did not prove superior to non-laboratory-based criteria alone, study finds

Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections